Search results
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 4 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 4 days agoU.S. sales of Humira plummeted by 39.9% year over year in the first quarter to $1.8 billion....
Treatment for Adult Diaper Rash
Verywell Health via Yahoo News· 6 days agoIt Be Something Else? A diaper rash can look similar to many other types of rashes. Other possible causes of rashes on or around the buttocks include:...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 2 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Got Tiny Blood Vessels on Your Face? Here's Why, and How To Treat Them
Well and Good· 3 days agoMore often than not, those red, spider-like clusters are just...broken blood vessels. Broken blood...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Do LED Skin-Care Devices Even Work?
New York Magazine· 3 days agoLight therapy via at-home LED (light-emitting diodes) devices is trending in skin care right now, but it’s not just a fad. According to Dr. Jared Jagdeo,...
Palisade's ulcerative colitis drug prevents symptoms in mice, is nontoxic in dogs
FierceBiotech· 1 day agoTwice-daily doses of Palisade's oral prodrug PALI-2108 for eight days protected mouse models of...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 3 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Tracking down the genetic causes of lupus to personalize treatment
Science Daily· 1 day agoResearchers are just now beginning to link specific genetic mutations to subsets of lupus patients, allowing physicians to target therapies to those who will benefit most. In the latest advance ...
